Does therapeutic equivalence follow bioequivalence? A randomized trial to assess clinical effects after switching from clozaril to generic clozapine (Gen-Clozapine)

Journal of Clinical Pharmacology

Volumn 50, Issue 5, 2010, Pages 531-535

  Oluboka, Oloruntoba ^a,b   Stewart, Sandra ^a   Landry, Suzette ^a   Adams, Susan ^a  

^a Northeast Mental Health Centre   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Clinical research; Clozaril; Disease management; Generic clozapine; Outcomes research; Psychiatry; Psychopharmacology; Switch

Indexed keywords

CLOZAPINE; GENERIC DRUG;

ADULT; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MONITORING; DRUG SUBSTITUTION; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SINGLE BLIND PROCEDURE;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUGS, GENERIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SINGLE-BLIND METHOD; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME;

EID: 77951183191     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009347871     Document Type: Article

References (19)

1. Gutierrez-Recacha P., Chisholm D., Haro JM, Salvador-Carulla L., Ayuso-Mateos JL Cost-effectiveness of different clinical interventions for reducing the burden of schizophrenia in Spain. Acta Psychiatr Scand. 2006 ; 114 (suppl 432). 29-38. (Pubitemid 44707080)
2. Kerwin R. When should clozapine be initiated in schizophrenia ? CNS Drugs. 2007 ; 21: 267-278.
3. Altamura AC, Bassetti R., Cattaneo E., et al. Some biological correlates of drug resistance in schizophrenia: a multidimensional approach. World J Biol Psychiatry. 2005 ; 6 (suppl 2). 23-30. (Pubitemid 41150413)
4. Cole JD, Goldberg SC, Davis JM Drugs in the treatment of psychosis: controlled studies. In: Solomon P, ed. Psychiatric Drugs. New York, NY: Groller and Stratton; 1966: 153-160.
5. Kinon BJ, Kane JM, Johns C., et al. Treatment of neuroleptic resistant schizophrenic relapse. Psychopharmacol Bull. 1993 ; 29: 309-314. (Pubitemid 23311541)
6. Baldessarini RJ, Frankenburg FR Clozapine: a novel agent. N Engl J Med. 1991 ; 324: 745-754.
7. Alessi-Severini S., Honcharik P., Simpson K., Eleff M., Collins D. Evaluation of an interchangeability switch in patients treated with clozapine: a retrospective review. J Clin Psychiatry. 2006 ; 67: 1047-1054. (Pubitemid 44230875)
8. Sajbel T., Carter G., Wiley R. Converting patients from brand-name clozapine to generic clozapine. Ann Pharmacother. 2001 ; 35: 281-284. (Pubitemid 32201710)
9. Kluznik J., Walbek N., Farnsworth M., Melstrom K. Clinical effects of a randomized switch of patients from clozaril to generic clozapine. J Clin Psychiatry. 2001 ; 62 (suppl 5). 14-17. (Pubitemid 32295159)
10. Mofsen R., Balter J. Case reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation. Clin Ther. 2001 ; 23: 1720-1731. (Pubitemid 33063595)
11. Stoner S., Lea J., Dubisar B., Marken P., Ramlatchman L., Reynolds J. A program to convert patients from trade-name to generic clozapine. Pharmacotherapy. 2003 ; 23: 806-810. (Pubitemid 36629084)
12. Makela E., Cutlip W., Stevenson J., et al. Branded versus generic clozapine for treatment of schizophrenia. Ann Pharmacother. 2003 ; 37: 350-353. (Pubitemid 36249632)
13. Paton C. Generic clozapine: outcomes after swithching formulations. Br J Psychiatry. 2006 ; 189: 184-185. (Pubitemid 44231281)
14. Overall J., Gorham D. The Brief Psychiatric Rating Scale. Psychol Rep. 1962 ; 10: 799-812.
15. Lingjaerde O., Ahlfors U., Bech P., Dencker S., Elgen K. The UKU Side Effect Rating Scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987 ; 334: 1-100. (Pubitemid 17115352)
16. Endicott J., Spitzer R., Fleiss J., Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976 ; 33: 766-771.
17. Guy W, ed. Clinical Global Impressions (ECDEU Assessment Manual for Psychopharmacology). Rockville, MD: US Department of Health, Education and Welfare; 1976.
18. Eisen S., Dill D., Grob M. Reliability and validity of a brief patient-report instrument for psychiatric outcome evaluation. Hosp Community Psychiatry. 1994 ; 45: 242-247. (Pubitemid 24079656)
19. SPSS (Version 17.0) [Computer software]. Chicago, IL: SPSS ; 2008.